Recent Finacing
Recent Raise
SYNAPS Dx develops DISCERN, an autopsy‑validated, minimally invasive blood test using three SDx biomarkers tied to PKC‑epsilon pathways to distinguish Alzheimer’s from other dementias, operating a CLIA‑certified high‑complexity lab.